Cheap drugs pulled despite wealth gap in middle-income countries

Most pharmaceutical and aid groups base their tiered pricing schemes for drug discounts on average per-capita income levels by country. But the growing wealth of many developing countries is adding a wrinkle to the calculus of which nations get cheap access to essential medicines. Some experts assert that basing prices on average income doesn’t work for the growing pool of middle-income countries, where many people are left below the poverty line and are therefore unable to afford medicine despite booms in local industries. Read more
Recent comments
Real-time tissue analysis could guide brain tumor surgery
Bundled RNA balls silence brain cancer gene expression
Ebola outbreak in West Africa lends urgency to recently-funded research